Your browser doesn't support javascript.
loading
Practical considerations for continuous glucose monitoring in elite athletes with type 1 diabetes mellitus: A narrative review.
Brar, Gurneet; Carmody, Sean; Lumb, Alistair; Shafik, Andrew; Bright, Chris; Andrews, Robert C.
Afiliação
  • Brar G; Royal United Hospital, Combe Park, Bath, UK.
  • Carmody S; Department of Orthopaedic Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam Movement Sciences, Amsterdam, The Netherlands.
  • Lumb A; Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Churchill Hospital, Claverton Down, Oxford, UK.
  • Shafik A; Department of Health, University of Bath, Claverton Down, Bath, UK.
  • Bright C; The Diabetes Football Community, UK.
  • Andrews RC; Institute of Biomedical and Clinical Sciences, Medical Research, University of Exeter Medical School, Royal Devon and Exeter Hospital, Exeter, UK.
J Physiol ; 602(10): 2169-2177, 2024 May.
Article em En | MEDLINE | ID: mdl-38680058
ABSTRACT
Type 1 diabetes mellitus (T1DM) refers to a metabolic condition where a lack of insulin impairs the usual homeostatic mechanisms to control blood glucose levels. Historically, participation in competitive sport has posed a challenge for those with T1DM, where the dynamic changes in blood glucose during exercise can result in dangerously high (hyperglycaemia) or low blood glucoses (hypoglycaemia) levels. Over the last decade, research and technological development has enhanced the methods of monitoring and managing blood glucose levels, thus reducing the chances of experiencing hyper- or hypoglycaemia during exercise. The introduction of continuous glucose monitoring (CGM) systems means that glucose can be monitored conveniently, without the need for frequent fingerpick glucose checks. CGM devices include a fine sensor inserted under the skin, measuring levels of glucose in the interstitial fluid. Readings can be synchronized to a reader or mobile phone app as often as every 1-5 min. Use of CGM devices is associated with lower HbA1c and a reduction in hypoglycaemic events, promoting overall health and athletic performance. However, there are limitations to CGM, which must be considered when being used by an athlete with T1DM. These limitations can be addressed by individualized education plans, using protective equipment to prevent sensor dislodgement, as well as further research aiming to (i) account for disparities between CGM and true blood glucose levels during vigorous exercise; (ii) investigate the effects of temperature and altitude on CGM accuracy, and (iii) explore of the sociological impact of CGM use amongst sportspeople without diabetes on those with T1DM.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Glicemia / Automonitorização da Glicemia / Diabetes Mellitus Tipo 1 / Atletas Limite: Humans Idioma: En Revista: J Physiol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Glicemia / Automonitorização da Glicemia / Diabetes Mellitus Tipo 1 / Atletas Limite: Humans Idioma: En Revista: J Physiol Ano de publicação: 2024 Tipo de documento: Article